Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Journal Article
Number of items: 4.

Journal Article

Hansen, Hinrich P., Engels, Hanna-Mareike, Dams, Maria, Paes Leme, Adriana F., Pauletti, Bianca Alves, Simhadri, Vijaya Lakshmi, Duerkop, Horst, Reiners, Katrin S., Barnert, Sabine, Engert, Andreas, Schubert, Rolf, Quondamatteo, Fabio, Hallek, Michael and von Strandmann, Elke Pogge (2014). Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma. J. Pathol., 232 (4). S. 405 - 415. HOBOKEN: WILEY. ISSN 1096-9896

Hansen, Hinrich P., Trad, Ahmad, Dams, Maria, Zigrino, Paola ORCID: 0000-0002-7470-0064, Moss, Marcia, Tator, Maximilian, Schoen, Gisela, Grenzi, Patricia C., Bachurski, Daniel ORCID: 0000-0001-9168-9680, Aquino, Bruno, Duerkop, Horst, Reiners, Katrin S., von Bergwelt-Baildon, Michael, Hallek, Michael, Groetzinger, Joachim, Engert, Andreas, Paes Leme, Adriana F. and von Strandmann, Elke Pogge (2016). CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro. Oncotarget, 7 (21). S. 30523 - 30536. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Lobastova, Liudmila, Lettau, Marcus, Babatz, Felix, de Oliveira, Thais Dolzany, Nguyen, Phuong-Hien, Pauletti, Bianca Alves, Schauss, Astrid C., Duerkop, Horst, Janssen, Ottmar ORCID: 0000-0002-9612-8900, Leme, Adriana F. Paes, Hallek, Michael and Hansen, Hinrich P. (2021). CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab Vedotin. Front. Cell. Dev. Biol., 9. LAUSANNE: FRONTIERS MEDIA SA. ISSN 2296-634X

Lobastova, Liudmila, Lettau, Marcus ORCID: 0000-0002-3824-9923, Babatz, Felix, de Oliveira, Thais Dolzany, Nguyen, Phuong-Hien, Pauletti, Bianca Alves, Schauss, Astrid C., Duerkop, Horst, Janssen, Ottmar, Paes Leme, Adriana F., Hallek, Michael and Hansen, Hinrich P. (2021). CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab Vedotin. Front. Cell. Dev. Biol., 9. LAUSANNE: FRONTIERS MEDIA SA. ISSN 2296-634X

This list was generated on Wed Apr 17 21:42:39 2024 CEST.